Fisher Scientific International Inc.Fisher Scientific International Inc.
2002 Annual ReportLetter to ShareholdersFisher At A GlanceQ & ALeadershipCorporate Information
Beyond ServiceBeyond BoundariesBeyond FulfillmentBeyond TechnologyFinancialsbacknext




 
Externally, what do you see as the key growth drivers in the near future?
Advances in life-science research, the aging population and its clinical needs, and the national priority placed on homeland security all provide near- and long-term growth opportunities for Fisher:
The shift in focus from genomics to proteomics (the study of human proteins controlled by genes) has opened up new possibilities for diagnosing and treating disease. Because we have millions of ever-changing proteins, scientists are intensifying their efforts to understand the role proteins play in disease, potential cures and prevention. With our offering of general lab supplies and consumables as well as our specialized life-science products and services, we are well positioned to take advantage of this change.
Aging population – People over 65 utilize five times more tests than younger people. As the baby-boom generation ages and new “designer” tests are developed, the demand for diagnostics and new drugs will increase dramatically.
Increased spending on homeland security is opening new markets for our broad range of personal-protection, decontamination and testing products, as well as our training programs and other services.
backnext   PAGE 5 of 6